US2560861096 - Common Stock
5.12 +0.07 (+1.39%)
NASDAQ:DCGO (9/28/2023, 10:18:15 AM)
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
DocGo, Inc. engages in the provision of mobile health services. The company is headquartered in New York City, New York and currently employs 2,064 full-time employees. The company went IPO on 2020-10-15. The firm uses dispatch and communication technology to help provide healthcare transportation and mobile services in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations, in metropolitan cities in the United States and the United Kingdom. Its segments include Transportation Services and Mobile Health Services. Its Transportation Services provides digitally enabled medical mobility solutions are offered under the Ambulnz brand. The company provides clinical services, including primary and specialty care, dialysis treatments for chronic care management, and transfers between clinical settings. Its Mobile Health Services perform at home and offices, testing, vaccinations and event services, including on-site healthcare support at sporting events and concerts. Its mobile health solutions include on-site evaluation, diagnostics, triage, and treatment.
35 West 35th St., Floor 6
New York City NEW YORK
DocGo's UK-based subsidiary, Ambulnz Community Partners, is introducing six electric ambulances to their fleet, as part of plans to go green and enhance...
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a n...
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DocGo Inc. ("DocGo" or the "Company") (NASDAQ: DCGO). Such investors are...
The beleaguered specialty healthcare provider announced a sudden change in leadership.
Here you can normally see the latest stock twits on DCGO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.